Preclinical and clinical evaluation of the effect of VARATCHUNDI ENNAI in the management of CHILDHOOD UNDER NUTRITION

Preclinical and clinical evaluation of the effect of VARATCHUNDI ENNAI in the management of VARAL MAANTHAM (CHILDHOOD UNDER NUTRITION)

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/11/047089

Enrollment

Registered

2022-11-07

Start date

Unknown

Completion date

Unknown

Last updated

2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E639- Nutritional deficiency, unspecified

Interventions

Intervention1: VARATCHUNDI ENNAI (Oral administration): Should be administered orally twice a day after food along with milk for 21 days. Dosage : 5 ml Control Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: Emaciation Pallorness Dizziness Dryness of upper and lower limbs Chillness of body Dryness of skin Oedema of upper and lower limbs Change in body build of children

Exclusion criteria

Exclusion criteria: Children below 1 year Childer above 5 years Moderate and sever malnutrition Childhood tuberculosis Childhood neoplasm

Design outcomes

Primary

Measure	Time frame
This study will help to understand the effect of VARATCHUNDI ENNAI in the management of VARAL MANTHAAM in children and the children with specific symptoms of VARAL MAANTHAM is expected to be cured.Timepoint: 21 DAYS	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactDR K SHYAMALA MD S

GOVERNMENT SIDDHA MEDICAL COLLEGE AND HOSPITAL PALAYAMKOTTAI

shyamsujisathya@gmail.com9442277124

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026